Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Exchange Rate Effect (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Exchange Rate Effect for 5 consecutive years, with -$9000.0 as the latest value for Q3 2025.

  • Quarterly Exchange Rate Effect fell 156.25% to -$9000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $28000.0 through Dec 2025, up 144.44% year-over-year, with the annual reading at $28000.0 for FY2025, 144.44% up from the prior year.
  • Exchange Rate Effect hit -$9000.0 in Q3 2025 for Kezar Life Sciences, down from $32000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $41000.0 in Q4 2022 to a low of -$75000.0 in Q4 2024.
  • Historically, Exchange Rate Effect has averaged -$7157.9 across 5 years, with a median of -$7000.0 in 2024.
  • Biggest five-year swings in Exchange Rate Effect: plummeted 392.31% in 2022 and later surged 966.67% in 2025.
  • Year by year, Exchange Rate Effect stood at $4000.0 in 2021, then soared by 925.0% to $41000.0 in 2022, then decreased by 7.32% to $38000.0 in 2023, then crashed by 297.37% to -$75000.0 in 2024, then soared by 88.0% to -$9000.0 in 2025.
  • Business Quant data shows Exchange Rate Effect for KZR at -$9000.0 in Q3 2025, $32000.0 in Q2 2025, and $5000.0 in Q1 2025.